News: Celera Licenses Oncology-Related Discoveries to LabCorp. Genetic Engineering News - Biotechnology from Bench to Business: "GEN News Highlights
Celera granted Laboratory Corporation of America� Holdings (LabCorp) rights to its breast cancer metastasis and estrogen/progesterone receptor discoveries. Many of the discoveries licensed to LabCorp are involved in the p53 tumor suppressor signaling pathways and are implicated in cancer proliferation."
